Studies focusing on melanoma have shown that B-cell infiltration in the TME results in the secretion of insulin-like growth factor 1 (IGF1), which promotes drug resistance to BRAF and MEK inhibitors [320]. The gene discussed is BRAF; the disease is melanoma.